Concepedia

Publication | Open Access

Effectiveness of Phosphodiesterase‐5 Inhibitor Therapy for Portopulmonary Hypertension

DOIFull Paper Access

36

Citations

34

References

2015

Year

Jolene H. Fisher, Sindhu R. Johnson, Cathy Chau, Amie Kron, John Granton
Canadian Respiratory Journal

Abstract

Phosphodiesterase-5 inhibitor therapy improved hemodynamics and functional class at six months in a cohort of patients with portopulmonary hypertension.

References

YearCitations

Page 1